• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Molecular mechanisms and target molecules associated with progression and treatment resistance of urologic cancers associated with microbiome alterations by diet and obesity

Research Project

Project/Area Number 23K21469
Project/Area Number (Other) 21H03064 (2021-2023)
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeMulti-year Fund (2024)
Single-year Grants (2021-2023)
Section一般
Review Section Basic Section 56030:Urology-related
Research InstitutionAkita University

Principal Investigator

Habuchi Tomonori  秋田大学, 医学系研究科, 教授 (00293861)

Co-Investigator(Kenkyū-buntansha) 堂前 直  国立研究開発法人理化学研究所, 環境資源科学研究センター, ユニットリーダー (00321787)
嘉島 相輝  秋田大学, 医学系研究科, 助教 (50842952)
南條 博  秋田大学, 医学部附属病院, 准教授 (70250892)
土谷 順彦  山形大学, 医学部, 教授 (70282176)
大山 力  弘前大学, 医学研究科, 特任教授 (80282135)
沼倉 一幸  秋田大学, 医学部附属病院, 講師 (90566415)
Project Period (FY) 2024-04-01 – 2025-03-31
Project Status Completed (Fiscal Year 2024)
Budget Amount *help
¥17,290,000 (Direct Cost: ¥13,300,000、Indirect Cost: ¥3,990,000)
Fiscal Year 2024: ¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2023: ¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2022: ¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2021: ¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Keywords肥満 / 高脂肪食 / 前立腺癌 / 癌 / 腸内細菌叢 / LPS / 腫瘍微小環境 / 免疫 / 腎癌 / サイトカイン / 高脂肪 / 腸内細菌 / 多価不飽和脂肪酸 / 癌進展 / 腫瘍免疫 / 飽和脂肪酸 / 腫瘍微少環境 / PI3K / 泌尿器癌 / 食事 / 治療抵抗性
Outline of Research at the Start

腸内細菌叢が泌尿器癌を含めた多くの癌の化学療法や免疫療法の成績に大きな影響を示すことや、食事、肥満や抗生剤投与によってこの腸内細菌群に変化を来し、 癌の進展や治療抵抗性に影響することが報告されている。
本研究ではメタボロミクス、細菌メタゲノム解析、等の包括的解析手法を生かして、食事と肥満、腸内細菌叢の変化による泌尿器癌進展の分子機構を腫瘍の微小環境変化と免疫系環境の変化に注目しながら、解明、標的分子を同定し、腸内細菌叢制御による泌尿器癌の進展予防や治療成績改善への可能性を検討した。

Outline of Final Research Achievements

The incidence of urologic cancers has been increasing significantly, and high-calorie and high-fat diets along with alterations of the gut microbiota have been suggested as contributing factors. In this study project, we aimed to elucidate the molecular mechanisms underlying the progression of urological cancers induced by dietary and obesity-related changes in the gut microbiota. In this project, we demonstrated that diets rich in saturated and monounsaturated fatty acids may promote prostate cancer (PC) progression by increasing specific gut microbial species and inducing overexpression of lipogenic genes in the tumor. Furthermore, we showed that changes in the gut microbiota and immune modulation induced by high intake of animal fats contribute to PC progression via systemic inflammatory responses involving LPS and intratumoral TGF-β signaling. The findings suggest that modulation of the gut microbiota could offer a promising approach to preventing PC and other cancer progression.

Academic Significance and Societal Importance of the Research Achievements

本研究の成果より、高脂肪食、高動物性脂肪食摂取による前立腺癌の進展に腸内細菌叢の変化(異常)が関与していることが示された。またこの腸内細菌叢の変化によって、LPS系の免疫応答、さらにはTGF-βシグナルが関与していることを示した。高脂肪食、高動物性脂肪食摂取による癌進展は前立腺癌に限った話ではなく、多くの癌種でしてきされており、本研究により腸内細菌叢の制御やLPS系の免疫応答、TGF-βシグナルを制御することにより、広く癌の発症や進展予防の戦略となる可能性があり、大きな医学・医療上の意義があると考えられる。

Report

(5 results)
  • 2024 Annual Research Report   Final Research Report ( PDF )
  • 2023 Annual Research Report
  • 2022 Annual Research Report
  • 2021 Annual Research Report
  • Research Products

    (33 results)

All 2024 2023 2022 2021 Other

All Journal Article (26 results) (of which Int'l Joint Research: 2 results,  Peer Reviewed: 26 results,  Open Access: 13 results) Presentation (4 results) (of which Int'l Joint Research: 3 results) Remarks (3 results)

  • [Journal Article] Primary resistance to nivolumab plus ipilimumab therapy affects second‐line treatment outcomes in patients with metastatic renal cell carcinoma2024

    • Author(s)
      Mori Kanami、Numakura Kazuyuki、Kimura Takahiro、Nishiyama Naotaka、Bando Yukari、Fujita Kazutoshi、Ueda Kosuke、Tanaka Hajime、Tomida Ryotaro、Kurahashi Toshifumi、Kitamura Hiroshi、Miyake Hideaki、Habuchi Tomonori
    • Journal Title

      Cancer Science

      Volume: 116 Issue: 2 Pages: 444-452

    • DOI

      10.1111/cas.16326

    • Related Report
      2024 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Prognostic model for second progression‐free survival and overall survival in patients with high‐risk metastatic hormone‐sensitive prostate cancer treated with abiraterone acetate and androgen deprivation therapy2024

    • Author(s)
      Narita Shintaro、Numakura Kazuyuki、Saito Mitsuru、Takayama Koichiro、Okane Katsumi、Ishida Toshiya、Horikawa Yohei、Kumazawa Teruaki、Shimoda Jiro、Iwabuchi Ikuya、Suzuki Takehiro、Ukimura Osamu、Kimura Takahiro、Ohyama Chikara、Nomura Kyoko、Habuchi Tomonori
    • Journal Title

      The Prostate

      Volume: 85 Issue: 1 Pages: 73-81

    • DOI

      10.1002/pros.24802

    • Related Report
      2024 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Influence of genetic polymorphisms in vascular endothelial-related genes on the clinical outcome of axitinib in patients with metastatic renal cell carcinoma2024

    • Author(s)
      Numakura Kazuyuki、Igarashi Ryoma、Takahashi Makoto、Nara Taketoshi、Kanda Sohei、Saito Mitsuru、Narita Shintaro、Inoue Takamitsu、Niioka Takenori、Miura Masatomo、Habuchi Tomonori
    • Journal Title

      Cancer Biology & Therapy

      Volume: 25 Issue: 1

    • DOI

      10.1080/15384047.2024.2312602

    • Related Report
      2024 Annual Research Report
    • Peer Reviewed
  • [Journal Article] The lymphocyte-to-monocyte ratio as a significant inflammatory marker associated with survival of patients with metastatic renal cell carcinoma treated using nivolumab plus ipilimumab therapy2024

    • Author(s)
      Numakura Kazuyuki、Sekine Yuya、Osawa Takahiro、Naito Sei、Tokairin Ojiro、Muto Yumina、Sobu Ryuta、Kobayashi Mizuki、Sasagawa Hajime、Yamamoto Ryohei、Nara Taketoshi、Saito Mitsuru、Narita Shintaro、Akashi Hideo、Tsuchiya Norihiko、Shinohara Nobuo、Habuchi Tomonori
    • Journal Title

      International Journal of Clinical Oncology

      Volume: 29 Issue: 7 Pages: 1019-1026

    • DOI

      10.1007/s10147-024-02538-8

    • Related Report
      2024 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Genome-wide association studies in advanced prostate cancer: KYUCOG-1401-A study2023

    • Author(s)
      Shiota Masaki、Tatarano Shuichi、Kamoto Toshiyuki、Matsuyama Hideyasu、Sakai Hideki、Igawa Tsukasa、Kamba Tomomi、Fujimoto Naohiro、Sekine Yuya、Kimura Hiroko、Narita Shintaro、Terada Naoki、Momozawa Yukihide、Akamatsu Shusuke、Habuchi Tomonori、Yokomizo Akira、Naito Seiji、Eto Masatoshi
    • Journal Title

      Endocrine-Related Cancer

      Volume: 30 Issue: 7

    • DOI

      10.1530/erc-23-0044

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Genetic variations predicting progression with docetaxel and novel androgen‐receptor pathway inhibitors2023

    • Author(s)
      Shiota Masaki、Akamatsu Shusuke、Sekine Yuya、Kimura Hiroko、Narita Shintaro、Fujimoto Naohiro、Terada Naoki、Blas Leandro、Habuchi Tomonori、Kamoto Toshiyuki、Momozawa Yukihide、Eto Masatoshi
    • Journal Title

      Cancer Science

      Volume: 114 Issue: 4 Pages: 1625-1634

    • DOI

      10.1111/cas.15718

    • Related Report
      2023 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Effect of HLA genotype on intravesical recurrence after bacillus Calmette-Guerin therapy for non-muscle-invasive bladder cancer.2022

    • Author(s)
      Kobayashi M, Fujiyama N, Tanegashima T, Narita S, Yamamoto Y, Fujimoto N, Ueda S, Takeuchi A, Numakura K, Habuchi T, Matsuyama H, Eto M, Shiota M.
    • Journal Title

      Cancer Immunol Immunother

      Volume: 71 (3) Issue: 3 Pages: 727-736

    • DOI

      10.1007/s00262-021-03032-0

    • Related Report
      2022 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Impact of Gleason pattern>=5 on prognosis for newly diagnosed metastatic hormone‐sensitive prostate cancer with Gleason score >=82022

    • Author(s)
      Morozumi Kento、Mitsuzuka Koji、Narita Shintaro、Takahashi Masahiro、Kawamura Sadafumi、Tochigi Tatsuo、Arai Yoichi、Hoshi Senji、Shimoda Jiro、Ishidoya Shigeto、Okamoto Teppei、Hatakeyama Shingo、Sakurai Toshihiko、Tsuchiya Norihiko、Ohyama Chikara、Habuchi Tomonori、Ito Akihiro
    • Journal Title

      International Journal of Urology

      Volume: 29 Issue: 4 Pages: 324-331

    • DOI

      10.1111/iju.14781

    • Related Report
      2022 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Clinical Utility of Germline Genetic Testing in Japanese Men Undergoing Prostate Biopsy2022

    • Author(s)
      Akamatsu Shusuke, Terada Naoki, Takata Ryo、...、Yamamoto Michio、...、Ogawa Osamu
    • Journal Title

      JNCI Cancer Spectrum

      Volume: 6 Issue: 1

    • DOI

      10.1093/jncics/pkac001

    • Related Report
      2022 Annual Research Report 2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] pecific Gut Microbial Environment in Lard Diet-Induced Prostate Cancer Development and Progression.2022

    • Author(s)
      Sato H, Narita S, Ishida M, Takahashi Y, Mingguo H, Kashima S, Yamamoto R, Koizumi A, Nara T, Numakura K, Saito M, Yoshioka T, Habuchi T.
    • Journal Title

      Int J Mol Sci.

      Volume: 23 Issue: 4 Pages: 2214-2214

    • DOI

      10.3390/ijms23042214

    • Related Report
      2022 Annual Research Report 2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Real-world survival outcomes of adding docetaxel or abiraterone in patients with high-volume metastatic castration-sensitive prostate cancer: historically controlled, propensity score matched comparison with androgen deprivation therapy2022

    • Author(s)
      Narita Shintaro、Kimura Takahiro、Hatakeyama Shingo、et al
    • Journal Title

      World Journal of Urology

      Volume: - Issue: 5 Pages: 1135-1141

    • DOI

      10.1007/s00345-022-03963-y

    • Related Report
      2022 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Association of Increased Age With Decreased Response to Intravesical Instillation of Bacille Calmette-Gu?rin in Patients With High-Risk Non-Muscle Invasive Bladder Cancer: Retrospective Multi-Institute Results From the Japanese Urological Oncology Research Group JUOG-UC-1901-BCG2022

    • Author(s)
      Inoue Takamitsu、Kobayashi Takashi、Nishiyama Naotaka、Kitamura Hiroshi、Nishiyama Hiroyuki、Fujimoto Kiyohide、Habuchi Tomonori
    • Journal Title

      Urology

      Volume: 167 Pages: 158-164

    • DOI

      10.1016/j.urology.2022.05.034

    • Related Report
      2022 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Effect of Levofloxacin on the Efficacy and Adverse Events in Intravesical Bacillus Calmette-Guerin Treatment for Bladder Cancer: Results of a Randomized, Prospective, Multicenter Study2022

    • Author(s)
      Numakura Kazuyuki、Kobayashi Mizuki、Ishida Toshiya、et al.
    • Journal Title

      European Urology Focus

      Volume: 8 Issue: 6 Pages: 1666-1672

    • DOI

      10.1016/j.euf.2022.06.002

    • Related Report
      2022 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Different risk genes contribute to clear cell and non-clear cell renal cell carcinoma in 1532 Japanese patients and 5996 controls.2022

    • Author(s)
      27)Sekine Y, Iwasaki Y, Aoi T, Endo M, Hirata M, Kamatani Y, Matsuda K, Sugano K, Yoshida T, Murakami Y, Fukui T, Akamatsu S, Ogawa O, Nakagawa H, Numakura K, Narita S, Habuchi T, Momozawa Y
    • Journal Title

      Human Molecular Genetics

      Volume: 31 Pages: 1962-1969

    • DOI

      10.1093/hmg/ddab345

    • Related Report
      2022 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Effect of upfront intensive therapy on oncological outcomes in older patients with high tumor burden metastatic castration‐sensitive prostate cancer: A multicenter retrospective study2022

    • Author(s)
      Miura Yuki、Hatakeyama Shingo、Narita Shintaro、Kimura Takahiro、Hata Kenichi、Yanagisawa Takafumi、Tanaka Toshikazu、Ishi Noritaka、Kawamura Sadafumi、Hoshi Senji、Ishidoya Shigeto、Mitsuzuka Koji、Ito Akihiro、Tsuchiya Norihiko、Egawa Shin、Habuchi Tomonori、Ohyama Chikara
    • Journal Title

      The Prostate

      Volume: 82 Issue: 13 Pages: 1304-1312

    • DOI

      10.1002/pros.24404

    • Related Report
      2022 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Does castration status affect docetaxel‐related adverse events? :Identification of risk factors for docetaxel‐related adverse events in metastatic prostate cancer2022

    • Author(s)
      Yanagisawa Takafumi、Kimura Takahiro、Hata Kenichi、Narita Shintaro、Hatakeyama Shingo、Enei Yuki、Atsuta Mahito、Mori Keiichiro、Obayashi Koki、Yoshihara Kentaro、Kondo Yosuke、Oguchi Takahiro、Sadakane Ibuki、Habuchi Tomonori、Ohyama Chikara、Shariat Shahrokh F.、Egawa Shin
    • Journal Title

      The Prostate

      Volume: 82 Issue: 14 Pages: 1322-1330

    • DOI

      10.1002/pros.24406

    • Related Report
      2022 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Machine learning diagnosis by immunoglobulin N-glycan signatures for precision diagnosis of urological diseases2022

    • Author(s)
      Iwamura H, Mizuno K, Akamatsu S, Hatakeyama S, Tobisawa Y, Narita S, Narita T, Yamashita S, Kawamura S, Sakurai T, Fujita N, Kodama H, Noro D, Kakizaki I, Nakaji S, Itoh K, Tsuchiya N, Ito A, Habuchi T, Ohyama C, Yoneyama T
    • Journal Title

      Cancer Science

      Volume: 113 Issue: 7 Pages: 2434-2445

    • DOI

      10.1111/cas.15395

    • Related Report
      2022 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Severe Immune-Related Adverse Events in Patients Treated with Nivolumab for Metastatic Renal Cell Carcinoma Are Associated with PDCD1 Polymorphism2022

    • Author(s)
      Kobayashi Mizuki、Numakura Kazuyuki、Hatakeyama Shingo、Muto Yumina、Sekine Yuya、Sasagawa Hajime、Kashima Soki、Yamamoto Ryohei、Koizumi Atsushi、Nara Taketoshi、Saito Mitsuru、Narita Shintaro、Ohyama Chikara、Habuchi Tomonori
    • Journal Title

      Genes

      Volume: 13 Issue: 7 Pages: 1204-1204

    • DOI

      10.3390/genes13071204

    • Related Report
      2022 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Impact of germline HLA genotypes on clinical outcomes in patients with urothelial cancer treated with pembrolizumab2022

    • Author(s)
      Takahashi Shuhei、Narita Shintaro、Ogawa Osamu、Habuchi Tomonori
    • Journal Title

      Cancer Science

      Volume: 113 Issue: 12 Pages: 4059-4069

    • DOI

      10.1111/cas.15488

    • Related Report
      2022 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Advanced Tertiary Lymphoid Tissues in Protocol Biopsies are Associated with Progressive Graft Dysfunction in Kidney Transplant Recipients2021

    • Author(s)
      Lee Yu Ho、Sato Yuki、Saito Mitsuru、Fukuma Shingo、Saito Masaya、Yamamoto Shigenori、Komatsuda Atsushi、Fujiyama Nobuhiro、Satoh Shigeru、Lee Sang-Ho、Boor Peter、Habuchi Tomonori、Floege J?rgen、Yanagita Motoko
    • Journal Title

      Journal of the American Society of Nephrology

      Volume: 33 Issue: 1 Pages: 186-200

    • DOI

      10.1681/asn.2021050715

    • NAID

      120007181755

    • Related Report
      2022 Annual Research Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] Altering phosphoinositides in high‐fat diet‐associated prostate tumor xenograft growth2021

    • Author(s)
      Huang Mingguo、Koizumi Atsushi、Narita Shintaro、Nakanishi Hiroki、Sato Hiromi、Kashima Soki、Nara Taketoshi、Kanda Sohei、Numakura Kazuyuki、Saito Mitsuru、Satoh Shigeru、Nanjo Hiroshi、Sasaki Takehiko、Habuchi Tomonori
    • Journal Title

      MedComm

      Volume: 2 Issue: 4 Pages: 756-764

    • DOI

      10.1002/mco2.89

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Macrophage inhibitory cytokine‐1 induced by a high‐fat diet promotes prostate cancer progression by stimulating tumor‐promoting cytokine production from tumor stromal cells2021

    • Author(s)
      Huang Mingguo、Narita Shintaro、Koizumi Atsushi、Nara Taketoshi、Numakura Kazuyuki、Satoh Shigeru、Nanjo Hiroshi、Habuchi Tomonori
    • Journal Title

      Cancer Communications

      Volume: 41 Issue: 5 Pages: 389-403

    • DOI

      10.1002/cac2.12137

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] The association between missense polymorphisms in SRD5A2 and HSD3B1 and treatment failure with abiraterone for castration-resistant prostate cancer2021

    • Author(s)
      Shiota Masaki、Akamatsu Shusuke、Narita Shintaro、Sumiyoshi Takayuki、Fujiwara Maki、Uchiumi Takeshi、Ogawa Osamu、Habuchi Tomonori、Eto Masatoshi
    • Journal Title

      The Pharmacogenomics Journal

      Volume: 1 Issue: 4 Pages: 1-1

    • DOI

      10.1038/s41397-021-00220-0

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Outcomes of axitinib versus sunitinib as first‐line therapy to patients with metastatic renal cell carcinoma in the immune‐oncology era2021

    • Author(s)
      Numakura Kazuyuki、Muto Yumin、Naito Sei、Hatakeyama Shingo、Kato Renpei、Koguchi Tomoyuki、Kojima Takahiro、Kawasaki Yoshihide、Kandori Syuya、Kawamura Sadafumi、Arai Yoichi、Ito Akihiro、Nishiyama Hiroyuki、Kojima Yoshiyuki、Obara Wataru、Ohyama Chikara、Tsuchiya Norihiko、Habuchi Tomonori
    • Journal Title

      Cancer Medicine

      Volume: 10 Issue: 17 Pages: 5839-5846

    • DOI

      10.1002/cam4.4130

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Clinical Impact of Detecting Low-Frequency Variants in Cell-Free DNA on Treatment of Castration-Resistant Prostate Cancer2021

    • Author(s)
      Kei Mizuno
    • Journal Title

      Clinical Cancer Research

      Volume: 28 Issue: 22 Pages: 6164-6173

    • DOI

      10.1158/1078-0432.ccr-21-2328

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Characteristics of α2,3‐sialyl N‐glycosylated PSA as a biomarker for clinically significant prostate cancer in men with elevated PSA level2021

    • Author(s)
      Yoneyama Tohru、Yamamoto Hayato、Sutoh Yoneyama Mihoko、Tobisawa Yuki, Hatakeyama Shingo, Narita Takuma, Ohyama Chikara, et al.
    • Journal Title

      The Prostate

      Volume: 81 Issue: 16 Pages: 1411-1427

    • DOI

      10.1002/pros.24239

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Presentation] Androgen deprivation therapy modifies gut microbial environment in patients with high-risk localized prostate cancer2024

    • Author(s)
      Ishida M, Narita S, Kobayashi M, Yamamoto R, Numakura K, Habuchi T
    • Organizer
      第111回日本泌尿器科学会総会
    • Related Report
      2024 Annual Research Report
  • [Presentation] Immune score of tumor-infiltrating CD8+ and FoxP3+ lymphocytes as a novel prognostic biomarker in high-risk localized prostate cancer who underwent radical prostatectomy.2023

    • Author(s)
      Hiromi Sato, Shintaro Narita, 9名略 Hiroshi Nanjo, Tomonori Habuchi
    • Organizer
      The 118th Annual Meeting of the American Urological Association
    • Related Report
      2023 Annual Research Report
    • Int'l Joint Research
  • [Presentation] Lard diet promotes prostate cancer progression through modulating gut microbiota and intratumoral lipid metabolism2023

    • Author(s)
      Hiromi Sato, Shintaro Narita, 8名略、 Toshiaki Yoshioka, Tomonori Habuchi
    • Organizer
      The 118th Annual Meeting of the American Urological Association
    • Related Report
      2023 Annual Research Report
    • Int'l Joint Research
  • [Presentation] Specific gut microbial environment and intratumoral lipid metabolism change in lard diet-induced prostate cancer progression2023

    • Author(s)
      Hiromi Sato, Shintaro Narita, 8名略、Toshiaki Yoshioka, Tomonori Habuchi
    • Organizer
      The 38th Annual European Association of Urology congress
    • Related Report
      2023 Annual Research Report
    • Int'l Joint Research
  • [Remarks] 秋田大学大学院医学系研究科 腎泌尿器科学講座

    • URL

      https://www.med.akita-u.ac.jp/~hinyoki/

    • Related Report
      2022 Annual Research Report
  • [Remarks] 研究/業績、秋田大学大学院医学系研究科 腎泌尿器科学講座

    • URL

      https://www.med.akita-u.ac.jp/~hinyoki/researcher/researchresults/index.html

    • Related Report
      2022 Annual Research Report
  • [Remarks] 秋田大学大学院医学系研究科 腎泌尿器科学 研究/業績

    • URL

      https://www.med.akita-u.ac.jp/~hinyoki/researcher/researchresults/index.html

    • Related Report
      2021 Annual Research Report

URL: 

Published: 2021-04-28   Modified: 2026-01-16  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi